**For best autofill requisition results, use Microsoft Edge or Internet Explorer**

To help provide the very best service, please use the autofill function on our requisitions or print all information legibly to ensure that your request is processed accurately.  Incomplete requisitions may delay the processing of testing and the subsequent reporting of results.  

A separate Requisition Form should be used for each patient and should be included with the accompanying sample.  Before shipping, please verify that patient information and patient ID number on the form matches that on the specimen.

Notice for all ordering providers, including external providers.

Effective Monday, January 3, 2022, all final results for orders placed through OHSU's Clinical laboratories will be immediately released to OHSU MyChart. In order to block immediate release, the ordering provider should notify OHSU on the requisition form - at the time the order is placed - of their reasonable belief that an information blocking exception applies.

This change is being made to comply with Oregon Law and the Federal Information Blocking Rule.

Knight Diagnostic Laboratories offers several requisitions to accommodate all client needs.  Please download from links below: 

Genetic Disorders

Constitutional Cytogenetics & FISH:

Molecular Genetics:

Infectious Diseases

Infectious Diseases:


Cancer Cytogenetics & FISH:

Hematologic Malignancies:

Solid Tumor:

Inherited Cancer Syndromes:

Consent Forms

The Knight Cancer Institute at Oregon Health & Science University is a pioneer in the field of precision cancer medicine. The institute's director, Brian Druker, M.D., helped prove it was possible to shut down just the cells that enable cancer to grow. This breakthrough has made once-fatal forms of the disease manageable and transformed how cancer is treated. The OHSU Knight Cancer Institute is the only National Cancer Institute-designated Cancer Center between Sacramento and Seattle – an honor earned only by the nation's top cancer centers. It is headquarters for one of the National Cancer Institute's largest research collaboratives, SWOG, in addition to offering the latest treatments and technologies as well as hundreds of research studies and clinical trials.

Learn More